Detailed information for compound 1759584

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 677.079 | Formula: C29H29ClN4O11S
  • H donors: 2 H acceptors: 8 LogP: 3.2 Rotable bonds: 14
    Rule of 5 violations (Lipinski): 2
  • SMILES: CC(=O)OC[C@H]1O[C@@H](Sc2nnc(n2/N=C/c2cc(Cl)ccc2O)c2ccccc2O)[C@@H]([C@H]([C@@H]1OC(=O)C)OC(=O)C)OC(=O)C
  • InChi: 1S/C29H29ClN4O11S/c1-14(35)41-13-23-24(42-15(2)36)25(43-16(3)37)26(44-17(4)38)28(45-23)46-29-33-32-27(20-7-5-6-8-22(20)40)34(29)31-12-18-11-19(30)9-10-21(18)39/h5-12,23-26,28,39-40H,13H2,1-4H3/b31-12+/t23-,24-,25+,26-,28+/m1/s1
  • InChiKey: VMQJLRZBHDQVDZ-OBPKRSRSSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Mycobacterium leprae Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas 0.0348 0.4752 0.6337
Trypanosoma cruzi mitogen activated protein kinase 2, putative 0.0212 0.213 0.5
Mycobacterium ulcerans phenolpthiocerol synthesis type-I polyketide synthase PpsE 0.0217 0.2228 0.2981
Mycobacterium leprae PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA 0.0328 0.4361 0.581
Mycobacterium leprae Probable polyketide synthase Pks1 0.0348 0.4752 0.6337
Mycobacterium leprae PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD 0.0328 0.4361 0.581
Mycobacterium leprae PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC 0.0348 0.4752 0.6337
Mycobacterium ulcerans phenolpthiocerol synthesis type-I polyketide synthase PpsC 0.0348 0.4752 0.6357
Trypanosoma cruzi mitogen-activated protein kinase 11, putative 0.0212 0.213 0.5
Mycobacterium leprae PROBABLE THIOESTERASE TESA 0.0273 0.3311 0.4398
Mycobacterium tuberculosis Probable fatty acid synthase Fas (fatty acid synthetase) 0.0103 0.0042 0.0056
Mycobacterium tuberculosis Probable thioesterase TesA 0.0273 0.3311 0.443
Mycobacterium tuberculosis Polyketide synthase Pks13 0.049 0.7476 1
Trichomonas vaginalis CMGC family protein kinase 0.0212 0.213 0.5
Brugia malayi Beta-ketoacyl synthase, N-terminal domain containing protein 0.0328 0.4361 0.4361
Mycobacterium ulcerans multifunctional mycocerosic acid synthase membrane-associated Mas 0.0348 0.4752 0.6357
Loa Loa (eye worm) hypothetical protein 0.0551 0.8643 1
Mycobacterium tuberculosis Phenolpthiocerol synthesis type-I polyketide synthase PpsD 0.0328 0.4361 0.5834
Mycobacterium tuberculosis Probable polyketide synthase Pks5 0.0318 0.4168 0.5576
Mycobacterium ulcerans phenolpthiocerol synthesis type-I polyketide synthase PpsB 0.0264 0.3131 0.4188
Trichomonas vaginalis CMGC family protein kinase 0.0212 0.213 0.5
Trypanosoma cruzi mitogen-activated protein kinase 11, putative 0.0212 0.213 0.5
Mycobacterium tuberculosis Phenolpthiocerol synthesis type-I polyketide synthase PpsA 0.0328 0.4361 0.5834
Mycobacterium ulcerans Type I modular polyketide synthase 0.0328 0.4361 0.5834
Giardia lamblia Kinase, CMGC MAPK 0.0212 0.213 0.5
Mycobacterium tuberculosis Phenolpthiocerol synthesis type-I polyketide synthase PpsC 0.0328 0.4361 0.5834
Trypanosoma cruzi mitogen activated protein kinase 4, putative 0.0212 0.213 0.5
Mycobacterium ulcerans polyketide synthase Pks9 0.0217 0.2228 0.2981
Mycobacterium tuberculosis Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) 0.0306 0.3948 0.528
Loa Loa (eye worm) hypothetical protein 0.0184 0.1592 0.0823
Mycobacterium ulcerans Type I modular polyketide synthase 0.0328 0.4361 0.5834
Mycobacterium tuberculosis Probable polyketide synthase Pks1 0.0236 0.2588 0.3461
Mycobacterium ulcerans polyketide synthase 0.0348 0.4752 0.6357
Mycobacterium ulcerans thioesterase TesA 0.0273 0.3311 0.443
Toxoplasma gondii type I fatty acid synthase, putative 0.0348 0.4752 1
Mycobacterium ulcerans polyketide synthase 0.0328 0.4361 0.5834
Mycobacterium ulcerans Type I modular polyketide synthase 0.0328 0.4361 0.5834
Mycobacterium tuberculosis Probable polyketide synthase Pks15 0.0133 0.061 0.0817
Mycobacterium tuberculosis Probable multifunctional mycocerosic acid synthase membrane-associated Mas 0.0348 0.4752 0.6357
Schistosoma mansoni serine/threonine protein kinase 0.0212 0.213 0.5
Brugia malayi AMP-binding enzyme family protein 0.0306 0.3948 0.3948
Mycobacterium ulcerans polyketide synthase Pks13 0.049 0.7476 1
Mycobacterium ulcerans phenolpthiocerol synthesis type-I polyketide synthase PpsD 0.0328 0.4361 0.5834
Mycobacterium leprae PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSE 0.0217 0.2228 0.2941
Onchocerca volvulus 0.0571 0.9025 0.9285
Mycobacterium tuberculosis Probable polyketide synthase Pks9 0.0186 0.1644 0.2199
Echinococcus multilocularis mitogen activated protein kinase 0.0212 0.213 0.5
Trypanosoma brucei protein kinase, putative 0.0212 0.213 0.5
Toxoplasma gondii type I fatty acid synthase, putative 0.0234 0.2547 0.3708
Leishmania major mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 0.0212 0.213 0.5
Mycobacterium tuberculosis Probable membrane bound polyketide synthase Pks6 0.049 0.7476 1
Toxoplasma gondii CMGC kinase, MAPK family (ERK) MAPK-1 0.0212 0.213 0.252
Loa Loa (eye worm) fatty acid synthase 0.0324 0.4277 0.4318
Leishmania major mitogen activated protein kinase, putative,map kinase, putative 0.0212 0.213 0.5
Onchocerca volvulus Fatty acid synthase homolog 0.0591 0.9416 1
Loa Loa (eye worm) CMGC/MAPK/ERK1 protein kinase 0.0212 0.213 0.1523
Mycobacterium ulcerans phenolpthiocerol synthesis type-I polyketide synthase PpsA 0.0264 0.3131 0.4188
Mycobacterium tuberculosis Probable polyketide synthase Pks7 0.0348 0.4752 0.6357
Toxoplasma gondii beta-ketoacyl synthase, N-terminal domain-containing protein 0.0213 0.2149 0.2574
Brugia malayi MAP kinase sur-1 0.0212 0.213 0.213
Mycobacterium tuberculosis Probable polyketide synthase Pks8 0.0268 0.3214 0.4299
Trichomonas vaginalis CMGC family protein kinase 0.0212 0.213 0.5
Trichomonas vaginalis CMGC family protein kinase 0.0212 0.213 0.5
Mycobacterium leprae PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB 0.0264 0.3131 0.4155
Trypanosoma brucei mitogen activated protein kinase 4, putative 0.0212 0.213 0.5
Mycobacterium ulcerans fatty acid synthase Fas 0.0103 0.0042 0.0056
Mycobacterium tuberculosis Polyketide synthase Pks12 0.0348 0.4752 0.6357
Echinococcus granulosus mitogen activated protein kinase 0.0212 0.213 0.5
Echinococcus granulosus mitogen activated protein kinase 3 0.0212 0.213 0.5
Mycobacterium leprae Polyketide synthase Pks13 0.049 0.7476 1
Echinococcus multilocularis mitogen activated protein kinase 3 0.0212 0.213 0.5
Mycobacterium ulcerans thioesterase 0.0273 0.3311 0.443
Mycobacterium tuberculosis Polyketide synthase Pks2 0.0318 0.4168 0.5576
Loa Loa (eye worm) AMP-binding enzyme family protein 0.0306 0.3948 0.3889
Mycobacterium tuberculosis Polyketide synthetase MbtC (polyketide synthase) 0.0113 0.0229 0.0306

Activities

Activity type Activity value Assay description Source Reference
MIC (functional) = 128 ug ml-1 Antibacterial activity against Escherichia coli ATCC 8099 after 24 hrs by NCCLS method ChEMBL. 23466234

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.